Tresiba 100 U/mL

Tresiba 100 U/mL is a long-acting insulin injection used for managing blood sugar levels in diabetes. This solution is designed for subcutaneous use and is manufactured by Novo Nordisk in the USA.

Tresiba 100 U/mL is primarily used for the management of diabetes. It helps control blood sugar levels over an extended period, making it suitable for daily use. This insulin solution is often prescribed for individuals requiring long-acting insulin therapy to maintain stable glucose levels.

Tresiba 100 U/mL works by mimicking the action of natural insulin in the body, helping to regulate blood sugar levels. Common effects may include improved glycemic control and reduced symptoms associated with high blood sugar. Individual responses can vary.

Tresiba 100 U/mL should be stored properly to maintain its effectiveness. It is important to follow the handling instructions provided by the manufacturer. Always consult a healthcare professional before starting or adjusting any insulin therapy.

Tresiba 100 U/mL may interact with other medications, including oral hypoglycemic agents and certain antibiotics. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be moderated.